Science Media Centre Spins Pro-GMO Line
By Rebekah Wilce,
PR Watch
| 04. 28. 2014
A new report commissioned by Prime Minister David Cameron suggests that GMOs have now been shown to be safe and that the United Kingdom may need to grow them in order to rely less on imports.
Since consumer campaigning got GMOs labeled and crop restricting implemented in the United Kingdom, Cameron will likely have a hard time convincing UK consumers that all is well. However, Cameron is getting help in that quest from a little known group called the Science Media Centre (SMC), which helped release the report to great fanfare. The Guardian and The Independent published prominent coverage of the report, and it was featured by the BBC. The Independent and BBC coverage were both entirely uncritical, quoting the scientists handpicked by the SMC for its reporters' briefing. The Guardian report was less glowing, but still quoted the SMC scientists and buried the reactions of critics below the fold. None of them mentioned that the report briefing was held by the SMC.
SMC calls itself an independent media briefing center for scientific issues. Critics, however, question its independence...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...